Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
BeOne Medicines
Eli Lilly and Company
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Nammi Therapeutics Inc
Beijing Biotech
Parabilis Medicines, Inc.
Exscientia AI Limited
Conjupro Biotherapeutics, Inc.
Zumutor Biologics Inc.
AstraZeneca
Agenus Inc.
858 Therapeutics, Inc.
Orano Med LLC
Filamon LTD
PMV Pharmaceuticals, Inc
AstraZeneca
Psyence Australia Pty Ltd
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
MBrace Therapeutics
Angiex, Inc.
IDEAYA Biosciences
Daiichi Sankyo
Guerbet
Adela, Inc
Doma Biopharmaceutical(Suzhou)Co., Ltd.
Natera, Inc.
Second Life Therapeutics
Phrontline Biopharma
Apollo Therapeutics Ltd
Innate Pharma
Dysplasia Diagnostics Limited
Complement Theory Inc.
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
NantCell, Inc.
Twinpig Biolab, Inc.
DualityBio Inc.
Nuvation Bio Inc.
Massive Bio, Inc.
Incyte Corporation
AVM Biotechnology Inc
Pfizer
Exelixis
3B Pharmaceuticals GmbH
Sensei Biotherapeutics, Inc.